Nopoulos noted that the survey would include administering psychedelics to a cohort of men with alcohol use disorder. Half of the participants will be administered psilocybin. In contrast, the other half will get ketamine, and neither the subjects nor the researchers will know which substance is being administered.
As the movement for marijuana legalization gains momentum across the United States, a significant barrier…
Conventional treatments prescribed to treat autoimmune conditions are focused on taming inflammation; these usually include…
Discover deals like daily $10 eighths for the holiday weekend and beyond at Giving Tree…
Verilife Non-Medical Cannabis is now available in Ohio. Open to customers 21+ with a valid…
At Verilife, there's always a stocked selection of top products & new favorites. Find the…
At Verilife, there's always a stocked selection of top products & new favorites. Find the…